Related Experiment Video
Updated: Oct 17, 2025

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
PABPC4 Broadly Inhibits Coronavirus Replication by Degrading Nucleocapsid Protein through Selective Autophagy
Yajuan Jiao1, Ning Kong1,2, Hua Wang1
1Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, People's Republic of China.
Abstract:
Emerging coronaviruses (CoVs) can cause severe diseases in humans and animals, and, as of yet, none of the currently available broad-spectrum drugs or vaccines can effectively control these diseases. Host antiviral proteins play an important role in inhibiting viral proliferation. One of the isoforms of cytoplasmic poly(A)-binding protein (PABP), PABPC4, is an RNA-processing protein, which plays an important role in promoting gene expression by enhancing translation and mRNA stability. However, its function in viruses remains poorly understood. Here, we report that the host protein, PABPC4, could be regulated by transcription factor SP1 and broadly inhibits the replication of CoVs, covering four genera (Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus) of the Coronaviridae family by targeting the nucleocapsid (N) protein through the autophagosomes for degradation. PABPC4 recruited the E3 ubiquitin ligase MARCH8/MARCHF8 to the N protein for ubiquitination. Ubiquitinated N protein was recognized by the cargo receptor NDP52/CALCOCO2, which delivered it to the autolysosomes for degradation, resulting in impaired viral proliferation. In addition to regulating gene expression, these data demonstrate a novel antiviral function of PABPC4, which broadly suppresses CoVs by degrading the N protein via the selective autophagy pathway. This study will shed light on the development of broad anticoronaviral therapies. IMPORTANCE Emerging coronaviruses (CoVs) can cause severe diseases in humans and animals, but none of the currently available drugs or vaccines can effectively control these diseases. During viral infection, the host will activate the interferon (IFN) signaling pathways and host restriction factors in maintaining the innate antiviral responses and suppressing viral replication. This study demonstrated that the host protein, PABPC4, interacts with the nucleocapsid (N) proteins from eight CoVs covering four genera (Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus) of the Coronaviridae family. PABPC4 could be regulated by SP1 and broadly inhibits the replication of CoVs by targeting the nucleocapsid (N) protein through the autophagosomes for degradation. This study significantly increases our understanding of the novel host restriction factor PABPC4 against CoV replication and will help develop novel antiviral strategies.
Insights
The host protein PABPC4 broadly inhibits coronavirus replication by targeting the nucleocapsid protein for degradation via selective autophagy. This discovery offers a new strategy for developing broad-spectrum antiviral therapies against coronaviruses.
Area of Science:
- Virology and Molecular Biology
- Host-Pathogen Interactions
- Innate Immunity
Background:
- Emerging coronaviruses (CoVs) pose significant threats to human and animal health, with limited effective treatments.
- Host antiviral proteins are crucial in controlling viral infections, but their roles against CoVs are not fully understood.
- Cytoplasmic poly(A)-binding protein PABPC4, known for gene expression regulation, has an unexplored function in antiviral defense.
Purpose of the Study:
- To investigate the role of the host protein PABPC4 in the replication of diverse coronaviruses.
- To elucidate the mechanism by which PABPC4 inhibits coronavirus proliferation.
- To explore the potential of PABPC4 as a target for broad-spectrum antiviral therapies.
Main Methods:
- Investigated the interaction of PABPC4 with nucleocapsid (N) proteins from eight CoVs across four genera.
- Examined the role of transcription factor SP1 in regulating PABPC4 expression.
- Studied the degradation pathway of the N protein mediated by PABPC4, involving E3 ligase MARCH8 and cargo receptor NDP52, leading to autophagosome-mediated clearance.
Main Results:
- PABPC4 broadly inhibits the replication of Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus genera.
- PABPC4 targets the viral nucleocapsid (N) protein for degradation through the selective autophagy pathway.
- PABPC4 recruits MARCH8 for N protein ubiquitination, which is then recognized by NDP52 for delivery to autolysosomes.
Conclusions:
- PABPC4 exhibits a novel, broad-spectrum antiviral function against coronaviruses by degrading the nucleocapsid protein.
- The SP1-PABPC4 axis and the selective autophagy pathway are key components of the host's defense against CoVs.
- PABPC4 represents a promising target for the development of novel, broad-acting antiviral strategies against emerging coronaviruses.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Antiviral System of Bacteria and Archaea: CRISPR
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity

